Lexaria Bioscience Corp (LEXX)

Finanzdaten der Lexaria Bioscience Corp-Aktie (LEXX)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-02-29	2023-11-30	2023-08-31	2023-05-31	2023-02-28
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	4.15% 0.145	0.1513	-0.00343	0.0932	0.035
Cost Of Revenue	100.00% -	0.00482	-	0.0127	0.00296
Gross Profit	0.99% 0.145	0.1465	-0.00343	0.0804	0.0321
Operating Expenses	36.76% 0.813	1.2856	1.0671	2.464	1.3427
Benefits Costs and Expenses	40.30% 0.7977	1.3363	1.2456	2.4767	1.3457
Costs And Expenses	40.30% 0.7977	1.3363	1.2456	2.4767	1.3457
Provision For Loan, Lease, And Other Losses	-	-	-	-	-
Depreciation and Amortization	44.64% 0.0159	0.0288	0.0709	0.025	0.0247
Operating Income/Loss	41.36% -0.668	-1.1391	-1.102	-2.3708	-1.3077
Net Interest Income/Expense	100.01% -0.000001	0.00732	-	-	-
Interest Income/Expense After Provision For Losses	100.01% -0.000001	0.00732	-	-	-
Income/Loss From Continuing Operations Before Tax	44.92% -0.6527	-1.185	-1.249	-2.3836	-1.3106
Income/Loss From Continuing Operations After Tax	44.92% -0.6527	-1.185	-1.249	-2.3836	-1.3106
Net Income/Loss	44.92% -0.6527	-1.185	-1.249	-2.3836	-1.3106
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	44.11% -0.00319	-0.00572	-0.0097	-0.0121	-0.0125
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-